Rela Institute Of Liver Disease And Transplantation Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 03-01-2025
- Paid Up Capital ₹ 0.10 M
as on 03-01-2025
- Company Age 6 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 16.31%
(FY 2022)
- Profit 46.53%
(FY 2022)
- Ebitda 85.75%
(FY 2022)
- Net Worth 52.50%
(FY 2022)
- Total Assets -22.48%
(FY 2022)
About Rela Institute Of Liver Disease And Transplantation
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Ramesh Krishnan, Shamsudin Rela, Thahira Rela, and One other member serve as directors at the Company.
- CIN/LLPIN
U85320TN2018PTC124653
- Company No.
124653
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 Sep 2018
- Date of AGM
28 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Kanchipuram, Tamil Nadu, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Rela Institute Of Liver Disease And Transplantation?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shamsudin Rela  | Managing Director | 19-Sep-2018 | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ramesh Krishnan | Director | 23-Jan-2019 | Current |
Thahira Rela  | Director | 27-Sep-2019 | Current |
| Ilankumaran | Director | 19-Sep-2018 | Current |
Financial Performance of Rela Institute Of Liver Disease And Transplantation.
Rela Institute Of Liver Disease And Transplantation Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 16.31% increase. The company also saw a substantial improvement in profitability, with a 46.53% increase in profit. The company's net worth Soared by an impressive increase of 52.5%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Rela Institute Of Liver Disease And Transplantation?
In 2021, Rela Institute Of Liver Disease And Transplantation had a promoter holding of 91.50% and a public holding of 8.50%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Rela Hospitals Private LimitedActive 6 years 3 monthsRamesh Krishnan, Shamsudin Rela and 1 more are mutual person
- Harsha Management Services Private LimitedActive 17 years 4 months
Shamsudin Rela is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Rela Institute Of Liver Disease And Transplantation?
Unlock and access historical data on people associated with Rela Institute Of Liver Disease And Transplantation, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Rela Institute Of Liver Disease And Transplantation, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rela Institute Of Liver Disease And Transplantation's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
